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Acquiring the ability to migrate is essential for cells
taking part in many developmental and disease pro-
cesses. Two studies in this issue of Developmental
Cell use gene expression profiling of purified border
cells from the Drosophila ovary to characterize the
molecular changes required in cells to initiate migra-
tion in vivo. Their results offer interesting new in-
sights into a moving cell’s physiology.
For cells just as for human beings, starting a major jour-
ney is an undertaking that requires careful preparation
and the marshalling of skills that are not normally
needed for a sedentary lifestyle. To exit a tissue and ini-
tiate migration, cells must extensively change their mo-
lecular makeup. They sever old connections and ac-
quire the ability to survive outside of their accustomed
environment while engaging in dramatic movements
and cell shape changes in pursuit of a guidance cue.
What are the changes in a cell’s physiology that allow
such massive transformations in its behavior? The an-
swer to this question should help us understand cell mi-
gration in such diverse biological processes as devel-
opment, immunity, or invasive growth of tumor tissue.
Consistent with a growing interest in the regulation
and mechanisms of cell migration, a multitude of differ-
ent examples are being studied extensively using cell
biological, biochemical, and genetic approaches (Franz
et al., 2002; Horwitz and Webb, 2003; Lehmann, 2001;
Ridley et al., 2003; Vicente-Manzanares et al., 2005).
Among the most accessible and powerful model sys-
tems to study invasive cell migration in an intact organ
is the migration of follicle border cells in the Drosophila
melanogaster ovary (Montell, 2003; Rorth, 2002). Border
cells are a group of 8–10 cells that is required for matu-
ration of the oocyte and the patterning of the early em-
bryo. During development of the egg chamber, these
cells delaminate from the follicular epithelium that sur-
rounds the oocyte and nurse cells, invade the underly-
ing germline tissue, and migrate to the anterior pole of
the oocyte.
The molecular characterization of border cell migra-
tion has progressed in great strides during the last de-
cade. Exhaustive genetic gain- and loss-of-function
screens have identified genes that are required for the
determination of border cells and for guiding their mi-
gration (Ribeiro et al., 2003; Starz-Gaiano and Montell,
2004). Some of these are part of signal transduction
pathways that elicit transcriptional responses in border
cells, mediated by transcription factors such as the
C/EBP homolog slow border cells (slbo). While it is clear
that Slbo activity is essential for border cell migration,
the makeup and function of the transcriptional program
that it regulates remain to be understood. Similarly, thegeneral transcriptome changes in border cells that allow
migration to initiate and proceed are unknown.
Two papers in this issue of Developmental Cell tackle
these issues (Borghese et al., 2006; Wang et al., 2006).
Both studies use genome-wide expression profiling of
purified border cell clusters to attempt a complete mo-
lecular description of genetic changes underlying the
physiology of a migrating cell. In addition to comparing
gene expression profiles of migrating cells with profiles
of nonmigrating cells of the ovary, they identify target
genes of Slbo by comparing slbo mutant with wild-
type border cells. Both groups use the ability to express
transgenes in specific cell populations of the fly (using
the Gal4/UAS system) to label border cells in vivo, purify
them, and extract RNA for microarray analysis. In both
cases, the functional significance of the obtained geno-
mic profiling data was verified genetically, taking advan-
tage of the powerful experimental arsenal that is at hand
in the Drosophila system.
Despite these similarities of goals and overall strat-
egy, the two groups used slightly different experimental
approaches and obtained different, albeit complemen-
tary, results. Due to their choice of Gal4 ‘‘driver,’’
Wang et al. labeled and purified two different popula-
tions of migratory cells in the ovary simultaneously: bor-
der cells and centripetal cells. Therefore, the resulting
gene expression profiles are more characteristic of mi-
gratory cells in general rather than of border cells spe-
cifically. To avoid the need for amplification of the
source material before hybridization to microarrays,
2000 ovary pairs were manually dissected for each con-
dition and the resulting mRNA population was probed
using Affimetrix oligonucleotide arrays representing
the entire genome. Expression data were obtained for
roughly 3000 genes, of which 413 were enriched in mi-
gratory cells, and 149 were slbo dependent. Subse-
quent RNA in situ hybridization identified genes specif-
ically enriched in border cells. Functional annotation of
enriched genes uncovered an overrepresentation of
genes involved in cytoskeletal regulation and the secre-
tory pathway. These findings illustrate the significant
changes in shape and adhesiveness associated with
the migratory state of a cell; drastic rearrangement of
the cytoskeleton and increased turnover of proteins
at the plasma membrane are likely required for these
tasks. Exemplifying the power of their approach for find-
ing new genes involved in migration, the authors se-
lected the receptor tyrosine kinase Tie for further ge-
netic analysis. Tie was found to be enriched in border
cells in a slbo-dependent manner, and the authors dem-
onstrate its requirement for border cell migration by
overexpressing a dominant-negative version of Tie spe-
cifically in border cells. Their results suggest that Tie in-
teracts with the guidance receptors EGFR and PVR.
Borghese et al. chose to label border cells more selec-
tively, using a ‘‘driver’’ that is active only in border cells.
GFP-labeled wild-type and slbo mutant border cells
were isolated by flow cytometry, and the extracted
RNA was amplified using a linear amplification method
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gratory follicle cells. The authors found 293 genes signif-
icantly enriched in border cells, 28% of which were also
regulated by slbo. These results were verified using RT-
PCR, RNA in situ hybridization, and immunostaining.
The border cell-enriched genes identified by Borghese
et al. correspond to a variety of functional groups,
most prominently general cytoskeletal regulators as
well as an intriguing group of genes heretofore consid-
ered ‘‘muscle-specific’’ (including rolling pebbles (rols),
a gene required for structural rearrangement of the cyto-
skeleton during myoblast fusion). Migrating border cells
might thus not only adjust their cell shape and adhesive-
ness, but also acquire ‘‘muscle-like’’ properties that al-
low them to actively invade the underlying tissue. The
authors further confirmed the significance of their ob-
tained gene expression profile for the migration of bor-
der cells in an exhaustive and thorough genetic exami-
nation. To this end, they assessed the rate of border
cell migration in mutants for a selection of genes from
different functional groups (including myosin heavy
chain, the microtubule regulator stathmin, rols, and the
transcription factors anterior open and vrille), demon-
strating their requirement for migration.
Both studies thus reveal how an elegant combination
of genetic and genomic approaches can be used to sig-
nificantly advance the molecular understanding of
a complex cellular process. The large number of border
cell-enriched and slbo-dependent genes identified is ex-
pected to guide efforts to understand how cell migration
is regulated and executed in vivo. The differing results of
the two studies do, however, also illustrate that genome-
wide expression profiles are never definitive descrip-
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Regulating Quiescence:
New Insights into
Hematopoietic Stem Cell Biology
Blood-forming hematopoietic stem cells (HSCs) en-
sure production of all mature blood cells during
homeostatic and regenerative hematopoiesis. Prolif-
eration, cell cycle regulation, and quiescence are key
processes involved in this function, and in a recent
issue of Cancer Cell, Lacorazza et al. (2006) show
that HSC quiescence is actively regulated by specific
molecular mechanisms that appear to distinguish nor-
mal HSC maintenance from HSC responses to hema-
tologic injury.
Analyses of genetically modified mice have been instru-
mental for our understanding of the roles of prolifera-
tion, cell cycle regulation, and quiescence in controllingmere snapshots of the dynamic physiology of cells. The
sheer number of parameters that affect cell function in
vivo clearly poses a significant experimental and con-
ceptual challenge. Our own journey to a complete de-
scription of even simple biological processes promises
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stem cell numbers and functions. In the March issue of
Cancer Cell, Lacorazza et al. (2006) identify the Ets tran-
scription factor MEF/ELF4 as a novel component of the
transcriptional circuitry that actively and dynamically
regulates HSC proliferation and quiescence. Using an
impressive array of in vitro and in vivo assays, the au-
thors show that loss of MEF expression in MEF2/2
mice slows HSC proliferation in response to cytokine
stimulation and leads to an accumulation of mitotically
quiescent (G0-phase) HSCs in vivo. Enhanced HSC qui-
escence in MEF2/2 animals also increases HSC resis-
tance to cytoablative agents that target dividing cells,
and allows more rapid hematopoietic recovery after
chemoablative treatment. Interestingly, although MEF2/2
HSCs are more quiescent during homeostasic hemato-
poiesis, they display rapid proliferation after chemo-
therapy, implying that homeostatic and regenerative
HSC proliferation invoke distinct regulatory and mecha-
nistic pathways, a possibility previously hinted at by
gene expression analyses (Venezia et al., 2004; Pas-
segue´ et al., 2005).
